Xiangyu Li
About Xiangyu Li
Xiangyu Li is an RA Senior Manager at BeiGene with extensive experience in pharmaceutical research and regulatory affairs.
Current Role at BeiGene
Xiangyu Li currently holds the position of RA Senior Manager at BeiGene, located in Suzhou, Jiangsu, China. He started this role on January 1, 2022. In this capacity, he is responsible for overseeing regulatory affairs, which includes ensuring compliance with all relevant regulations and guidelines.
Previous Experience at Baxter International Inc.
Before his current role, Xiangyu Li worked at Baxter International Inc. as a Manager II/Research Scientist II. He was with the company for five years, from 2017 to 2022, in Suzhou, Jiangsu, China. His responsibilities included research and development, focusing on pharmaceutical sciences and processes.
Educational Background
Xiangyu Li pursued his education in pharmaceutical sciences. He earned his Doctor of Pharmacy (PharmD) from Freie Universität Berlin, where he studied from 2013 to 2016. Prior to that, he achieved his Master's Degree in Pharmaceutics from Yanbian University, studying there from 2002 to 2009.
Specialization and Expertise
Xiangyu Li has extensive expertise in the submission of Abbreviated New Drug Applications (ANDA) to regulatory bodies such as the FDA, EMA, and NMPA. He specializes in formulation development, focusing on nanoparticles and nanoparticle-loaded semi-solid dosage forms. His strong background in analytical chemistry has contributed significantly to various projects in this field.
Early Career Roles
Earlier in his career, Xiangyu Li served in various roles that helped build his expertise. In 2012, he worked as a Pharmacy Technician at Freie Universität Berlin for six months. In 2011, he was an RA Specialist at Sinopharm A Think Pharmaceutical Ltd in Jilin Changchun, China, for three months. From 2009 to 2011, he worked as an Analytical Researcher at Beijing Lunarsun Pharmaceutical Co., Ltd in Beijing City, China.